Status: Not yet recruiting
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
To evaluate the efficacy and safety of DWP712 Inj. in Subjects with Moderate to Severe Glabellar Lines
Participants needed: 324
Trial details
Phase: Phase 3Age: 19-65Biological sex: AllType: InterventionalSponsor: Daewoong Pharmaceutical Co. LTD.Updated: Jun 10, 2025Locations: 1
Eligibility criteria
Not listed